Veloxis Pharmaceuticals
Veloxis Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic products for transplant patients. The company was acquired in 2020 by Asahi Kasei, a Japanese multinational conglomerate, though it maintains operations in Denmark and the United States.
Brand Identity Data
HQ Country
Denmark
HQ City
Amerika Plads
Founded
1999
EU Headquartered
Yes
EU Manufactured
No
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026